| Bioactivity | Flobetapir (AV-45) may be a well-tolerated imaging agent. Flobetapir synthesizes Florbetapir (18F) that is a PET scanning radiopharmaceutical compound containing the radionuclide fluorine-18[1]. | ||||||||||||
| Invitro | Flobetapir may be a well-tolerated imaging agent[1]. | ||||||||||||
| Name | Flobetapir | ||||||||||||
| CAS | 938435-69-9 | ||||||||||||
| Formula | C20H25FN2O3 | ||||||||||||
| Molar Mass | 360.42 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Flobetapir May Be Successful Imaging Agent From Scientific Point of View [2]. Wong DF, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18) [published correction appears in J Nucl Med. 2010 Aug;51(8):1327]. J Nucl Med. 2010;51(6):913-920. |